BC
ALB icon

Barrett & Company’s Albemarle ALB Stock Holding History

Barrett & Company’s Portfolio ALB Stock Details ALB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38K Buy
+25
New +$4.41K ﹤0.01% 585

Other funds holding ALB

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Barrett & Company's ALB Position: Q2 2026 in Review

Barrett & Company opened a new position in Albemarle (ALB) in Q2 2026: 25 shares worth $3.38K. The stake represents ﹤0.01% of the portfolio and ranks #585 among its holdings.

937 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Barrett & Company held 25 shares of Albemarle worth $3.38K as of Q2 2026.
  • Albemarle was a new Barrett & Company position in Q2 2026.
  • Albemarle made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #585 holding.
  • 937 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.